Health CareHealth Care Providers
  • Price (EUR)50.50
  • Today's Change0.300 / 0.60%
  • Shares traded31.12k
  • 1 Year change-25.13%
  • Beta0.7971
Data delayed at least 15 minutes, as of May 25 2022 16:35 BST.
More ▼
Take Action
Take Action
Add this security to watchlist, portfolio, or create an alert to track market movement

Events & Activity

  • COPX.N:GER price moved over +1.20% to 50.75
  • COPX.N:GER price rises above 15-day moving average to 50.35 at 10:00 BST
  • COPX.N:GER price falls below 15-day moving average to 50.30 at 10:50 BST
  • COPX.N:GER price rises above 15-day moving average to 50.40 at 10:00 BST

Key statistics

On Wednesday, CompuGroup Medical SE & Co KgaA (COPX.N:GER) closed at 50.50, 13.74% above the 52 week low of 44.40 set on Mar 11, 2022.
52-week range
44.40Mar 11 202282.80Sep 07 2021
Markit short selling activity
Previous close50.20
Average volume43.39k
Shares outstanding53.73m
Free float27.73m
P/E (TTM)35.32
Market cap2.70bn EUR
EPS (TTM)1.42
Annual div (ADY)0.50
Annual div yield (ADY)1.00%
Div ex-dateMay 20 2022
Div pay-dateMay 24 2022
Data delayed at least 15 minutes, as of May 25 2022 16:35 BST.
More ▼
An LSEG Business
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
Markit Short Selling Activity © Markit. All rights reserved.
Although Markit has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of Markit on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.